Book Now
Blush Injectables Logo on Pink

Anti-Wrinkle Injections Botox®, Relfydess®, Dysport® & Xeomin®

Expression lines are proof you've lived a life full of laughing, frowning, squinting into the sun and everything in between. Anti-wrinkle injections work on the limiting the movement of muscles which in turn softens the lines that linger after the expression's gone.

With four clinically proven options on hand, Botox®, Dysport®, Xeomin® and Relfydess®, your treatment plan is built around your face and your goals. Behind every treatment is Dominique Lieder, a Registered Nurse who's worked alongside some of New Zealand's leading surgeons and specialists in appearance medicine.

The different types of toxins

Botox®

The original and most recognised anti-wrinkle brand worldwide, used safely in cosmetic medicine for decades. A well-studied option for forehead lines, frown lines and crow's feet, particularly where a precise, controlled result matters.

Dysport®

A clinically proven botulinum toxin treatment with a slightly different spread to Botox®, which can suit larger treatment areas well.

Xeomin®

A purified botulinum toxin type A, free from the complexing proteins found in some other formulations. Xeomin® treats the same key areas, frown lines, crow's feet and forehead lines.

Relfydess®

The newest anti-wrinkle option available in New Zealand. Relfydess® is a next generation botulinum toxin with a unique strain and no added proteins, developed for a faster onset (some clients notice results within a few days) and reported longer lasting effects.

How Anti-Wrinkle Injections Work

Anti-wrinkle injections contain a purified form of botulinum toxin type A. Injected into specific facial muscles, it temporarily reduces the movements that cause lines and wrinkles. As the muscles relax, the skin above them smooth out, resulting in a softer complexion with reduced lines and wrinkles.

 Results are typically visible from 2 days to two weeks and can last from 3-6 months depending on the product used. 

What to expect from your anti-wrinkle appointment

Consultation The first step is to book a consultation to assess whether anti-wrinkle injections are right for you. In this 30-minute free consultation, Dominique will talk through your options and recommendations for what you are hoping to achieve.

First appointment/Consultation Your consultation can also be combined with your first treatment and this takes around 45 minutes. This is the most popular starting point for new clients. 

Follow-up appointment Dominique will check in two weeks after your treatment to assess results and make any small adjustments. Allow 30 minutes.

Maintenance appointments To keep results consistent, book a maintenance appointment every three to six months, depending on which product you're using and how long your results last. Regular treatment typically means less product is needed to maintain your result.

Book A Consultation
Anti-Wrinkle Treatments
RELFYDESS® prescription medicine contains 150 units of relabotulinumtoxinA for the treatment of frown lines and crow's feet around the eyes. Relfydess has risks and benefits. Ask your healthcare professional if Relfydess is right for you and to explain the possible side effects. Tell them if any side effects concern you. Always follow the instructions you are given. For details on precautions and side effects, see the Consumer Medicines Information at www.medsafe.govt.nz. Galderma, Auckland.
Botox® is a prescription medicine containing 100 units of Clostridium Botulinum Type A toxin complex for injection. It is used for the treatment of severe frown lines and associated "crow's feet" around the eyes. It should be administered only by trained medical professionals. Talk to your specialists about the benefits/risks of this procedure in appearance medicine. Cautions: people with neuro-muscular transmission disorders, presence of infection at site of injection, pregnancy and lactation. Possible side effects include headaches, pain, burning sensation or redness at injection site, temporary local muscle weakness including eyelid droop, decreased sensation and nausea. If you have side effects or concerns, talk to your doctor. A charge applies. Allergan Pharmaceutical, Auckland.
Dysport® is a prescription medicine for the treatment of frown lines, horizontal forehead lines and crow's feet around the eyes. Dysport® has risks and benefits. Ask your doctor if Dysport is right for you. If you have side effects see your doctor. You will need to pay for Dysport, and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz. Dysport lasts about 4-6 months and further courses of treatment may be necessary. Should only be administered by trained medical professionals. Contains 500 units of clostridium botulinum Type A toxin. Galderma (NZ) Limited, Auckland.

 

Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection. It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin® treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. Treatment last for up to 4 months. You will need to pay for this medicine. Discuss with your specialist if Xeomin® is right for you. For more information or for a copy of CMI please contact the NZ distributor: Merz, Sydney. Distributed by Healthcare Logistics, Auckland.

 

 

Skin Boosters
To learn more about VISCODERM® HYDROBOOSTER go to www.ibsaderma.co.nz
VISCODERM® HYDROBOOSTER is a Class III medical device containing 25mg/1mL of cross-linked hyaluronic acid, it is used to restore intradermal hydration and to keep improve the structure and elasticity of the skin. VISCODERM® HYDROBOOSTER must only be administered by a medical practitioner or a qualified nurse injector (who operates under the supervision of a medical practitioner). Treatment costs and normal practitioner’s fees will apply. VISCODERM® HYDROBOOSTER has risks and benefits. If you have side effects or concerns, speak to your medical practitioner. Please consult your medical practitioner regarding its suitability for you. For further product information, please refer to your medical practitioner or the Instructions for Use leaflet at Dermocosmética PTY LTD, Australia.
Made in Italy. VISCODERM® HYDROBOOSTER is a registered trademark of IBSA. IBSA Farmaceutici S.r.l Via Martiri di Cefalonia 2 26900 Lodi – Italy. Distributed in New Zealand by Dermocosmética (NZBN 9429050049066) Suite A, Floor 8 Harbourview Building, 152 Quay St, Auckland Central, Auckland, New Zealand, through Healthcare Logistics. 58 Richard Pearse Drive, Airport Oaks, Manukau City, Auckland, New Zealand.
Copyright © Dermocosmetica 2024. All rights reserved. No part of this publication may be stored in a retrieval system or reproduced by any means whatsoever without written consent of the publisher.

 

Profhilo®, containing low & high molecular weight hyaluronic acid, is a Class III medical device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem. Profhilo® has risks and benefits. Do not use with treatments such a laser resurfacing or medium deep skin-peeling. Caution in people on blood thinning medicines. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

 

Sunekos 1200 is an implantable medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. It is suitable for creating a temporary increase in the volume of skin tissue. Sunekos 1200 is a medical device that is sterile, injectable, non-pyrogenic, biocompatible, re-absorbable, made with hyaluronic acid and amino acids. Sunekos Performa is a medical device recommended for the treatment of blemishes and depressions in the skin caused by wrinkles and scars. Sunekos Performa is a sterile resorbable injectable solution which acts as a filler, supporting the restoration of physiological elasticity and temporarily replacing volume by expanding the soft tissues. Sunekos should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for use before prescribing for full safety information, available from www.xytide.co.nz New Zealand Sponsor: AA-Med Pty Ltd Distributed by: Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036.
Dermal Fillers
Restylane® is a gel containing hyaluronic acid and lidocaine that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane is a Class III medical device and has risks and benefits. Restylane® treatment may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can begin up to two to four weeks after treatment in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Restylane® should not be used in an area where there is a nonresorbable implant or in irritated or infected skin, Restylane® should not be used in people taking blood thinning medicines or who have an allergy to hyaluronic acid, lidocaine or other local anaesthetics. Caution if you take medicines that prolong bleeding time. Treatment lasts 12-24 months. Restylane has not been tested in pregnant or breast-feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN. Galderma, Auckland. Distributed by Healthcare Logistics, Auckland.

 

e.p.t.q. Lidocaine is a sterile, non-pyrogenic, viscoelastic, colourless, transparent gel composed of cross-linked sodium hyaluronate gel of non-animal origin with 0.3% lidocaine hydrochloride in a physiologic phosphate buffer. e.p.t.q. Lidocaine is an injectable gel (also called a dermal filler) used for the correction of nasolabial folds. e.p.t.q. Lidocaine is produced with hyaluronic acid (HA), the HA of the gel is made from a non-animal source. e.p.t.q. Lidocaine should not be used on patients: with known hypersensitivity to any of its components; presenting with a general infection, inflammatory or infectious cutaneous problems; with history of severe multiple allergies or anaphylactic shock; prone to hypertrophic scars/keloids or streptococcal diseases; in patients presenting with porphyria; under 18 years of age; in pregnancy or lactation; others. See full Instructions for Use before prescribing for full safety information, available from www.xytide.co.nz. Copyright© 2024. Xytide Biotech Pty Ltd. Always read the label and follow the instructions. This medical device must be administered by a Healthcare Professional. New Zealand Sponsor Xytide Biotech NZ Pty Ltd (NZBN 9429049668612) C/O Alliott Ltd, Level 2, 142 Broadway, Newmarket, Auckland 1023 NZ. For more information please phone +61 1800 570 036

Bio-stimulators

Radiesse® injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands. Radiesse® injectable implant is indicated for: the treatment of nasolabial folds, marionette lines or jawline; the augmentation of cheeks; the hand augmentation to correct volume loss in the dorsum of the hands; and the restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus. Radiesse® (+) Lidocaine injectable implant is intended for plastic and reconstructive surgery, including deep dermal and sub-dermal soft tissue augmentation of the facial area and dorsum of the hands in adults. Radiesse® (+) Lidocaine injectable implant is indicated for: the treatment of nasolabial folds, marionette lines and jawline; the augmentation of cheeks; hand augmentation to correct volume loss in the dorsum of the hands; the restoration and/or correction of the signs of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands fat loss (lipoatrophy) in people with human immunodeficiency virus. You should tell your practitioner and avoid treatment with Radiesse®/Radiesse® (+) Lidocaine if you: have had an allergic reaction to any of the ingredients or have severe allergies including anaphylaxis; if you tend to develop keloids or heavy scars; have any bleeding disorders, poor wound healing; inflamed or infected skin; are under the age of 18; are pregnant or breastfeeding. Please inform your practitioner of any diseases you have or have had. These include in particular cardiovascular diseases, autoimmune diseases, diabetes, tumors, skin infections or severe allergies. If you take medication or vitamins, have had previous cosmetic procedures, or have been treated with other implants, please inform your practitioner. Always read the label and consult your Healthcare Professional for more information. This medical device must be administered by a Healthcare Professional. Merz Australia Pty Ltd (ACN: 151 073 559) Sydney, Australia. NZ Distribution: Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL). 58 Richard Pearse Drive, Mangere, Auckland 2022. For more information please phone 0800 822 310.

Juvelook® and Juvelook Volume are Class III Medical Devices containing PDLLA (poly-D,L-lactic acid) and hyaluronic acid, developed in Korea. These collagen-stimulating injectables are designed for intradermal and subcutaneous implantation to correct skin depressions, restore facial volume, and improve skin texture through natural collagen regeneration. Intended for use by registered healthcare professionals only, Juvelook® and Juvelook Volume are indicated for the treatment of fine lines, acne scars, enlarged pores, nasolabial folds, under-eye hollows, and mid-face volume loss. They help refine facial contours, smooth wrinkles, and support long-lasting skin rejuvenation with natural-looking results. Both products carry potential risks and benefits. Treatment with Juvelook® and Juvelook Volume may cause injection site reactions, swelling, or bruising. Consult your healthcare professional to understand the full range of possible side effects and discuss any concerns.  These products  have not been studied in pregnant or breastfeeding women, or in individuals under 18 years of age. Results may last from 9 to 18 months depending on individual factors.
 Always follow the instructions provided by your healthcare professional.
Juvelook and Juvelook Volume are registered trademarks of Vaim Co., Ltd. and exclusivey distributed in NZ by YB Aesthetics.